The PRINCIPLE randomised controlled open label platform trial of hydroxychloroquine for treating COVID19 in community based patients at high risk

ABSTRACT:

SUBMITTER: Hobbs F 

PROVIDER: S-EPMC12227643 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature